Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens
- 1 June 1998
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (6) , 405-412
- https://doi.org/10.1007/bf01691573
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolonesDiagnostic Microbiology and Infectious Disease, 1996
- In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and SlovakiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Activity of trovafloxacin against blood isolates ofStreptococcus pneumoniae in SwedenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- In Vitro Antimicrobial Activity of CP-99,219, a New 7-AzabicyclonaphthyridoneDrugs, 1995
- In vitro antimicrobial susceptibility of glycopeptide-resistant enterococciDiagnostic Microbiology and Infectious Disease, 1995
- In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobialDiagnostic Microbiology and Infectious Disease, 1994
- Mechanisms of quinolone resistanceInfection, 1994